CHEK1 and head and neck squamous cell carcinoma: According to a very recent study focused on the use of mitotic inhibitors in HNSCC, mutations in AJUBA, SMAD4 and RAS predict the sensitivity to CHK1 and WEE1 inhibitors [102].